Ewa Haładyj

Statistics

Publications

Citations

273

H-Index

Active since

2016

Affiliations

National Institute of Geriatrics, Rheumatology and Rehabilitation(Current)

Eli Lilly (United States)

Medical University of Warsaw

Inserm

Centre de Recherche Épidémiologie et Statistique

Ewa Haładyj is an author at National Institute of Geriatrics, Rheumatology and Rehabilitation specializing in medicine, rheumatoid arthritis, and rheumatology.

ORCID

Publications per year

2016–2024

Publications

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study

Marta Tonello, Ariela Hoxha, Savino Sciascia et al. · Thrombosis and Haemostasis · 2018 · 87 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +15

Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis

Agnieszka Paradowska‐Gorycka, Andrzej Pawlik, Katarzyna Romanowska‐Próchnicka et al. · PLoS ONE · 2016 · 46 citations · Full text

Medicine, Internal Medicine, Molecular Genetics +17

Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications

Peter C. Taylor, Thomas Bieber, Rieke Alten et al. · Advances in Therapy · 2023 · 38 citations · Full text

Medicine, Dermatology, Pharmacology +17

Rivaroxaban – a safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases

Ewa Haładyj, Marzena Olesińska · Reumatologia/Rheumatology · 2016 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases

Piotr Wojdasiewicz, Anna Wajda, Ewa Haładyj et al. · Reumatologia/Rheumatology · 2019 · 17 citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +16

1–5 of 9